Daniel Eitzman, MD

 Daniel T. Eitzman
Professor
Email:
[email protected]
Available to mentor
Daniel Eitzman, MD
Daniel T. Eitzman
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Global REACH
    • Center Member
      Frankel Institute for Heart and Brain Health
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    • Center Member
      Caswell Diabetes Institute

    Recent Publications

     See All Publications
    • Journal Article
      Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
      Wang J, Silaghi P, Eitzman DT. Journal of Thrombosis and Haemostasis, 2026 Jul 1; 24 (7): 2593 - 2599. DOI:10.1016/j.jtha.2026.03.026
      PMID: 41941897
    • Journal Article
      The first in-human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT-678 in acute coronary syndrome patients and healthy volunteers
      Liu Z, Liu S, Gong Y, Chi X, Wang T, Fan F, Qu C, Lou Y, Zhang L, Zhang B, Yang F, Mohetaboer M, Wang J, Qiu L, Miao L, Lu Y, You R, He P, Li Y, Yi T, Weng H, Xia Y, Wang C, Shi Q, Wang Z, Jiang Y, Li Y, Han C, Wang Y, Wang X, Yang C, Chen YE, Eitzman DT, Zhang H, Li J. British Journal of Pharmacology, 2025 Jan 1; 182 (1): 131 - 141. DOI:10.1111/bph.17355
      PMID: 39367653
    • Journal Article
      Inhibition of sodium-glucose cotransporter-2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model
      Wang J, Silaghi P, Guo C, Harro D, Eitzman DT. Journal of Cellular and Molecular Medicine, 2024 Sep 1; 28 (17): DOI:10.1111/jcmm.70091
      PMID: 39267208
    • Journal Article
      Beta1-receptor blockade attenuates atherosclerosis progression following traumatic brain injury in apolipoprotein E deficient mice
      Wang J, Venugopal J, Silaghi P, Su EJ, Guo C, Lawrence DA, Eitzman DT. Plos One, 2023 May 1; 18 (5 May): DOI:10.1371/journal.pone.0285499
      PMID: 37235594
    • Journal Article
      RESOLUTION OF SICKLE CELL CRISIS FOLLOWING ADMINISTRATION OF AMIODARONE
      Silaghi P, Eitzman DT. European Journal of Case Reports in Internal Medicine, 2023 Jan 1; 10 (6): DOI:10.12890/2023_003879
    • Journal Article
      Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate
      Venugopal J, Wang J, Guo C, Eitzman DT. Scientific Reports, 2022 Dec 1; 12 (1): DOI:10.1038/s41598-022-20955-5
      PMID: 36180774
    • Preprint
      Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate
      Venugopal J, Wang J, Guo C, Eitzman DT. 2022 Mar 18; Research Square, DOI:10.21203/rs.3.rs-1442536/v1
    • Journal Article
      Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling
      Venugopal J, Wang J, Guo C, Eitzman DT. British Journal of Haematology, 2022 Feb 1; 196 (4): 1040 - 1051. DOI:10.1111/bjh.17941
      PMID: 34786709